Bautista-Lopez, N., et al., Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine, 2000. 18(14): p. 1393-401 https://www.ncbi.nlm.nih.gov/pubmed/10618537.
Benfield, T., Rämet M., Valentini P., et al. 'Safety, Tolerability, and Immunogenicity of V114 Pneumococcal Vaccine Compared with PCV13 in a 2+1 Regimen in Healthy Infants: A Phase III Study (PNEU-PED-EU-2).' Vaccine, vol. 41, no. 15, Apr. 2023, pp. 2456–65. https://doi.org/10.1016/j.vaccine.2023.02.041.
Beyea SC, Nicoll LH. Administration of medications via the intramuscular route: an integrative review of the literature and research-based protocol for the procedure. Appl Nurs Res. 1995 Feb;8(1):23-33. doi: 10.1016/s0897-1897(95)80279-7. PMID: 7695353.
Bili, A., Dobson S., Quinones J., et al. 'A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Interchangeability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, and PCV13 with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION).' Vaccine, vol. 41, no. 3, Jan. 2023, pp. 657–65. https://doi.org/10.1016/j.vaccine.2022.10.072.
Blyth, C.C., Jayasinghe, S., Andrews R.M. 'A Rationale for Change: An Increase in Invasive Pneumococcal Disease in Fully Vaccinated Children.' Clinical Infectious Diseases, June 2019, p. ciz493. https://doi.org/10.1093/cid/ciz493.
Brown GC, Volk VK, Gottshall RY, Kendrick PL, Anderson HD. Responses of infants to (Difterie, Tetanus en Poliomyelitis) vaccine used in nine injection schedules. Public Health Rep. 1964;79:585-602.
De Groot, R, T. Oomen, G. Vermeulen, J.A. van Vliet. Handhygiëne in de jeugdgezondheidszorg, ook bij het vaccineren? Infectieziekten Bulletin, maart 2014.
DeSilva M, Vazquez-Benitez G, Nordin JD, Lipkind HS, Klein NP, Cheetham TC, et al., Maternal DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. Lancet Infect Dis. 2018.
Furck Block, S.L., et al., Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Tdap vaccination and risk of infant morbidity. Vaccine. 2017;35(29):3655-60.
Gans, H.A., et al., Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. J Infect Dis, 2013. 207(4): p. 574-82.
Hilgersom JA, (Algemene arbeidsongeschiktheidswet) van Boekel, HC Rümke. 'Aanvallen na vaccinatie van zuigelingen en peuters'. Tijdschr Jeugdgezondheidsz (2017) 49:2–7 DOI 10.1007/s12452-016-0092-4 Januari 2017 https://apps.who.int/iris/bitstream/10665/255353/1/WER9219.pdf.
Lupinacci, R., Rupp R., Wittawatmongkol O., et al. 'A Phase 3, Multicenter, Randomized, Double-Blind, Active-Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4-Dose Regimen of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Healthy Infants (PNEU-PED).' Vaccine, vol. 41, no. 5, Jan. 2023, pp. 1142–52. https://doi.org/10.1016/j.vaccine.2022.12.054.
Macartney, K.K., Chiu, C., Georgousakis, M. et al. Safety of Human Papillomavirus Vaccines: A Review. Drug Saf 36, 393–412 (2013). https://doi.org/10.1007/s40264-013-0039-5.
Markowitz, L.E., et al., Immunization of six-month-old infants with different doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children.
Nicoll LH, Hesby A. Intramuscular injection: an integrative research review and guideline for evidence-based practice. Appl Nurs Res. 2002 Aug;15(3):149-62. doi: 10.1053/apnr.2002.34142. PMID: 12173166.
Puthanakit T., Schwarz T., Esposito S., Frenette L., McNeil S., Rheault P.6 Horn M., Poncelet S., Suryakiran P., Hezareh M., Thomas F., Descamps D., Struyf F. Immune responses to a 2-dose schedule of the HPV-16/18 as04-adjuvanted vaccine in girls (9-14) versus 3 doses in women (1525): a randomised trial Chulalongkorn University, Faculty of Medicine, Department of Pediatrics, Division of Infectious Diseases, Bangkok 2013.
(Rijksinstituut voor Volksgezondheid en Milieu)-notitie: Nynke Rots, Nicoline van der Maas, Hans van Vliet, Laura Antonise-Kamp; Timing van vaccinatie tegen kinkhoest tijdens de zwangerschap. RIVM 3 september 2019.
WHO Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region 2010.
WHO. (2019). 'Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.' Vaccine 37(2): 223-225.
Vaccinatie van gezonde zwangeren tegen griep. Achtergronddocument bij Griepvaccinatie: herziening van de indicatiestelling 2021, Gezondheidsraad, Nr. 2021/39A/04, 2021.
Duvekot JJH, van de Laar LY, Schreuder I. Vanaf dit najaar griepvaccinatie voor álle zwangeren [Influenza vaccination from this autumn for all pregnant women: less influenza infections among neonates and pregnant women]. Ned Tijdschr Geneeskd. 2023;167:D7850.
Foo DYP, Sarna M, Pereira G. Early Childhood Health Outcomes Following In Utero Exposure to Influenza Vaccines: A Systematic Review.Pediatrics. 2020-08-01;146(2).
Geersing TH, Hilgersom WJA, Tempels-Pavlica Ž, Rümke HC, de Koning LCMJ, Borgsteede SD. Overgevoeligheidsreacties en vaccins [Hypersensitivity reactions and vaccines]. Ned Tijdschr Geneeskd. 2017;161:D1491.
Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants.N Engl J Med 2014; 371(10): 918-931.
Nunes MC, Madhi SA. Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis.Hum Vaccin Immunother 2018; 14(3): 758-766.
Omer SB, Clark DR, Madhi SA, Tapia MD, Nunes MC, Cutland CL, et al. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials.Lancet Respir Med 2020; 8(6): 597-608.
Steinhoff MC, Katz J, Englund JA, Khatry SK, Shrestha L, Kuypers J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.Lancet Infect Dis 2017; 17(9): 981-989.
Tapia MD, Sow SO, Tamboura B, Teguete I, Pasetti MF, Kodio M, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, activecontrolled, observer-blind, randomised phase 4 trial.Lancet Infect Dis 2016; 16(9): 1026-1035.
